Dr. Allen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44199 Dequindre
Suite 311
Troy, MI 48085Phone+1 248-964-9490- Is this information wrong?
Education & Training
- Henry Ford HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
- Beaumont Health (Royal Oak)Residency, Internal Medicine, 1997 - 2000
- McLaren Health Care/Macomb/MSUInternship, Internal Medicine, 1996 - 1997
- Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1996
Certifications & Licensure
- MI State License 1997 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- ACLS/BLSCompletion
Awards, Honors, & Recognition
- Hour Magazine Top Doctor Hour Magazine, 2022
- Hour Magazine Top Doctors Hour Magazine, 2021
- Hour Magazine Top Doctors Hour Mafazine, 2020
- Join now to see all
Clinical Trials
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
- Join now to see all
Publications & Presentations
PubMed
- 69 citationsCombination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trialR. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda, Kuo Yang Wang, Ekkehard Grünig, Shirish Hiremath, Zaixin Yu, Gangchen...> ;American Journal of Respiratory and Critical Care Medicine. 2020 Mar 15
- Selexipag for the Treatment of Pulmonary Arterial Hypertension.Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galie N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zen...> ;N Engl J Med. 2015 Dec 24
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.Galie N, Barbera JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grunig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, ...> ;N Engl J Med. 2015 Aug 27
- Join now to see all
Press Mentions
- Michigan’s Definition of Coronavirus ‘Recovery’ Looser Than Other StatesMay 10th, 2020
- If You Have Coronavirus, Here's How to Protect the People You LoveMarch 24th, 2020
- Does Vaping Contribute to More Coronavirus Cases? Here's What Doctors SayMarch 25th, 2020
Research History
- Research Director Pulmonary Hypertension CenterMultiple International studies / registries / site-initiated studies. Many publications2008 - Present
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Member
Hospital Affiliations
- Corewell Health Troy HospitalTroy, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: